Recombinant Xylella fastidiosa Thymidylate synthase (thyA)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please consult your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and may serve as a useful reference.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
thyA; PD_1364; Thymidylate synthase; TS; TSase; EC 2.1.1.45
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-264
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Xylella fastidiosa (strain Temecula1 / ATCC 700964)
Target Names
thyA
Target Protein Sequence
MKQYLELLND VLVHGIKKPD RTGTGTRSVF GWQMRFDLSQ GFPLVTTKKL HLRSIIHELL WFLRGETNIA YLKKHQVHIW DEWADATGEL GPVYGKQWRR WAGADGHEID QIRWLVEEIK RNPDSRRLVI SAWNVADLPQ MALVPCHALF QFYVANGKLS CQLYQRSADI FLGVPFNIAS YALLTHMLAQ VTGLVVGDFV HTLGDAHLYA NHVEQASVQL GRVPRPQPVL RLNQAVTDLF DFTYDDIVIE GYDPYPAIKA PVAV
Uniprot No.

Target Background

Function
Thymidylate synthase (ThyA) catalyzes the reductive methylation of 2'-deoxyuridine-5'-monophosphate (dUMP) to 2'-deoxythymidine-5'-monophosphate (dTMP) using 5,10-methylenetetrahydrofolate (mTHF) as both the methyl donor and reductant. Dihydrofolate (DHF) is produced as a byproduct. This reaction provides a crucial intracellular de novo source of dTMP, an essential precursor for DNA synthesis.
Database Links

KEGG: xft:PD_1364

Protein Families
Thymidylate synthase family, Bacterial-type ThyA subfamily
Subcellular Location
Cytoplasm.

Q&A

What is the role of thymidylate synthase in Xylella fastidiosa metabolism?

Thymidylate synthase (encoded by the thyA gene) plays a critical role in Xylella fastidiosa metabolism by catalyzing the conversion of dUMP to dTMP through the transfer of a methylene group from methylene-H4-folate, with concomitant oxidation of H4-folate to H2-folate. This reaction is essential for DNA synthesis and cellular replication as it provides the sole de novo source of thymidylate. In X. fastidiosa, this enzyme is particularly important for survival in nutrient-poor environments such as plant xylem, where the bacterium must synthesize essential compounds that aren't readily available from the host . The enzyme integrates with folate metabolism pathways that are crucial for bacterial survival and growth within the restrictive xylem environment.

How does thyA expression differ among Xylella fastidiosa subspecies?

The expression of thyA can vary significantly among the four major Xylella fastidiosa subspecies (fastidiosa, multiplex, sandyi, and pauca), which have diverged genetically by 1-3% due to geographical isolation over approximately 20,000-50,000 years . These subspecies show host specificity patterns that may be related to differential gene expression, including thyA. Comparative studies suggest that variations in thyA expression could be associated with adaptations to different host plants, as these subspecies have evolved to colonize distinct plant species. The genetic divergence between subspecies may include regulatory elements affecting thyA expression, potentially influencing their metabolic capabilities in different host environments .

What structural features distinguish Xylella fastidiosa thymidylate synthase from other bacterial homologs?

X. fastidiosa thymidylate synthase maintains the core catalytic domain structure common to bacterial thymidylate synthases but contains subspecies-specific amino acid variations that may influence substrate binding affinity and catalytic efficiency. The enzyme typically forms a homodimer with each monomer containing a nucleotide binding domain and catalytic site. Analysis of conserved regions shows that while the active site residues are generally preserved across bacterial species, the X. fastidiosa enzyme exhibits unique structural features, particularly in surface-exposed loops that may interact with regulatory proteins specific to its metabolic network. These structural distinctions could be relevant to the development of targeted antimicrobial compounds that specifically inhibit X. fastidiosa without affecting beneficial bacteria.

What are the optimal expression systems for producing recombinant Xylella fastidiosa thymidylate synthase?

The optimal expression system for recombinant X. fastidiosa thymidylate synthase depends on the research objectives. For high-yield protein production, E. coli BL21(DE3) with pET vector systems has proven effective, particularly when the coding sequence is codon-optimized for E. coli expression. For functional studies requiring proper folding and post-translational modifications, yeast expression systems such as Pichia pastoris may be preferable. When designing the expression construct, consider including:

  • A histidine or other affinity tag for purification

  • A protease cleavage site to remove the tag if necessary for activity assays

  • Appropriate promoters (T7 for E. coli, AOX1 for P. pastoris)

Expression conditions typically require optimization of:

  • Induction temperature (often lowered to 16-25°C to improve solubility)

  • Inducer concentration (0.1-1.0 mM IPTG for E. coli systems)

  • Duration of expression (4-24 hours)

  • Media composition (supplementation with folate precursors may improve yield)

How can researchers address solubility challenges when expressing recombinant thyA from Xylella fastidiosa?

Solubility challenges with recombinant X. fastidiosa thyA can be addressed through multiple strategies:

ApproachImplementationExpected Outcome
Temperature optimizationExpress at 16-20°C instead of 37°CReduced aggregation and inclusion body formation
Fusion partnersUse solubility-enhancing tags (MBP, SUMO, Trx)Improved folding and solubility
Co-expressionInclude chaperones (GroEL/GroES, DnaK/DnaJ)Assisted protein folding
Buffer optimizationTest various pH ranges (7.0-8.5) and salt concentrations (100-500 mM NaCl)Enhanced stability in solution
AdditivesInclude glycerol (5-10%), reducing agents (1-5 mM DTT)Prevented aggregation and oxidation
Refolding protocolsGradual dilution from denaturing conditionsRecovery of active protein from inclusion bodies

When expressing X. fastidiosa thyA, researchers should also consider adding folate pathway metabolites to the expression media, as these may stabilize the enzyme during expression. Additionally, using host strains with reduced protease activity, such as E. coli BL21(DE3) pLysS, can help prevent degradation of the target protein.

What purification strategies yield the highest activity for recombinant Xylella fastidiosa thyA?

To obtain highly active recombinant X. fastidiosa thyA, a multi-step purification approach is recommended:

  • Initial capture: Immobilized metal affinity chromatography (IMAC) using Ni-NTA resin for His-tagged constructs, maintaining 1-5 mM 2-mercaptoethanol throughout purification to protect active site cysteine residues.

  • Intermediate purification: Ion exchange chromatography, typically using Q-Sepharose at pH 8.0 (thyA typically has a pI around 6.0-6.5).

  • Polishing step: Size exclusion chromatography to separate active dimers from aggregates and monomers, using buffers containing 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, and 1 mM DTT.

Activity preservation measures should include:

  • Adding glycerol (10-20%) to storage buffers

  • Maintaining reducing conditions (1-5 mM DTT or TCEP)

  • Including folate or folate analogs (10-100 μM) to stabilize the enzyme

  • Flash-freezing aliquots in liquid nitrogen and storing at -80°C

The specific activity of the purified enzyme should be assessed using the traditional spectrophotometric assay measuring the conversion of dUMP to dTMP at 340 nm in the presence of methylene tetrahydrofolate and NADPH.

How should researchers design activity assays for Xylella fastidiosa thyA to accurately reflect in vivo conditions?

To design activity assays for X. fastidiosa thyA that accurately reflect in vivo conditions, researchers should consider the unique xylem environment where the bacterium naturally grows. The following methodological approach is recommended:

  • Buffer composition: Use buffer systems that mimic xylem sap composition with appropriate pH (typically 5.5-6.5) and mineral content based on analysis of host plant xylem fluid.

  • Substrate concentrations: Determine physiologically relevant concentrations of dUMP (typically 10-100 μM) and methylene tetrahydrofolate (typically 20-200 μM) based on bacterial metabolite profiling.

  • Co-factor requirements: Include essential ions such as Mg²⁺ (1-5 mM) that are required for optimal activity.

  • Temperature range: Conduct assays at temperatures relevant to plant hosts (20-30°C) rather than standard laboratory conditions.

  • Inhibitor evaluation: Include plant-derived compounds known to be present in xylem sap, particularly phenolic compounds that might modulate enzyme activity in vivo .

The traditional spectrophotometric assay monitoring the increase in absorbance at 340 nm can be modified to include these conditions. Additionally, isothermal titration calorimetry (ITC) can provide valuable information about substrate binding under various conditions that mimic the xylem environment.

What techniques can identify potential regulatory interactions of thyA in the Xylella fastidiosa folate metabolic network?

To identify regulatory interactions of thyA within the X. fastidiosa folate metabolic network, researchers should employ a multi-faceted approach:

  • Protein-protein interaction studies:

    • Co-immunoprecipitation with anti-thyA antibodies followed by mass spectrometry

    • Bacterial two-hybrid system optimized for X. fastidiosa proteins

    • In vitro pull-down assays using purified recombinant thyA as bait

  • Metabolic profiling:

    • Quantitative analysis of folate pathway intermediates using LC-MS/MS in wild-type versus thyA mutant strains

    • Flux analysis using isotope-labeled precursors to track metabolic changes

  • Transcriptional regulation:

    • ChIP-seq to identify proteins binding to the thyA promoter region

    • Reporter gene assays using thyA promoter constructs to identify regulatory elements

  • Post-translational modifications:

    • Phosphoproteomic analysis to identify potential regulatory phosphorylation sites

    • Analysis of other modifications (e.g., acetylation, methylation) by mass spectrometry

These approaches should be conducted comparing X. fastidiosa grown in standard media versus xylem sap-mimicking conditions to identify environmentally responsive regulatory mechanisms . The data should be integrated with existing pathway models to develop a comprehensive understanding of thyA regulation within the folate metabolic network.

How can researchers accurately assess the impact of thyA mutations on Xylella fastidiosa fitness in different plant hosts?

To accurately assess the impact of thyA mutations on X. fastidiosa fitness across different plant hosts, researchers should implement a comprehensive experimental approach:

  • Generation of defined genetic modifications:

    • Create precise thyA point mutations using CRISPR-Cas9 or allelic exchange methods

    • Develop thyA deletion mutants with complementation constructs

    • Generate thyA reporter fusions to monitor expression in planta

  • In vitro growth characterization:

    • Compare growth rates in defined media and host plant xylem sap extracts

    • Evaluate stress responses (oxidative, nutritional limitation) relevant to plant colonization

    • Assess biofilm formation and cell aggregation capabilities

  • Plant inoculation experiments:

    • Use multiple host plant species representing different susceptibility levels

    • Implement standardized inoculation protocols (needle or insect-mediated)

    • Monitor bacterial population dynamics at different time points post-inoculation

    • Quantify bacterial populations using culture-dependent and qPCR methods

  • Host response assessment:

    • Measure disease symptom development using standardized rating scales

    • Analyze host transcriptional responses to wild-type versus mutant strains

    • Examine xylem vessel occlusion patterns and plant defense responses

This methodology allows for a comprehensive evaluation of thyA contribution to fitness across the infection cycle and provides insights into host-specific adaptation mechanisms, particularly in the context of the bacterium's ability to survive in the challenging xylem environment .

How has intersubspecific recombination influenced thyA evolution in Xylella fastidiosa populations?

Intersubspecific homologous recombination (IHR) has played a significant role in thyA evolution within X. fastidiosa populations. Research indicates that recombination events between previously geographically isolated subspecies (fastidiosa, multiplex, sandyi, and pauca) have created novel genetic variants with potentially altered host ranges .

The thyA gene serves as an interesting marker for these recombination events. Analysis of sequence data reveals evidence of introgression between subspecies, particularly between X. fastidiosa subsp. fastidiosa and X. fastidiosa subsp. multiplex . These recombination events can be detected through:

  • Sequence analysis showing chimeric alleles containing segments from different subspecies

  • Incongruence between phylogenies constructed from different genomic regions

  • Statistical tests such as the introgression test showing significant evidence of gene flow

The recombination affecting thyA and other housekeeping genes appears to have functional consequences, potentially contributing to host adaptation. For example, recombinant strains showing evidence of IHR have been associated with infections in novel plant hosts like blueberry and blackberry that were not typically colonized by non-recombinant parent strains . This suggests that thyA variants resulting from recombination may contribute to metabolic adaptations that facilitate colonization of new plant species, highlighting the importance of horizontal gene transfer in bacterial adaptation and evolution.

What structural and functional differences exist between thyA in Xylella fastidiosa and related plant pathogenic bacteria?

Comparative analysis of thymidylate synthase (thyA) between Xylella fastidiosa and related plant pathogenic bacteria reveals several structural and functional differences:

FeatureXylella fastidiosa thyAthyA in Related Plant PathogensFunctional Implications
Active site residuesContains subspecies-specific variationsMore conserved across speciesMay affect substrate specificity and catalytic efficiency
Regulatory domainsUnique N-terminal extension in some strainsTypically shorter N-terminal regionsPotential for differential regulation in response to environmental signals
Substrate binding pocketMore restrictive binding pocketGenerally more flexible binding sitesMay influence sensitivity to inhibitors and substrate analogs
Oligomeric statePrimarily forms dimersSome related species form tetramersAffects allosteric regulation and stability
Temperature sensitivityOptimum activity at 25-28°CMany related species optimum at 30-37°CAdaptation to xylem environment temperatures
pH profileActive in slightly acidic conditions (pH 5.5-6.5)Often optimal at neutral pH (6.8-7.5)Adaptation to xylem sap acidity

These differences reflect the evolutionary adaptation of X. fastidiosa to its specialized ecological niche in plant xylem vessels. The unique structural features of X. fastidiosa thyA may contribute to the bacterium's ability to survive in the nutrient-poor xylem environment . Additionally, these differences could be exploited for the development of targeted antimicrobial compounds that specifically inhibit X. fastidiosa thyA without affecting beneficial bacteria or host plant enzymes.

How does the functional interaction between thyA and folate metabolism differ in Xylella fastidiosa compared to model organisms like E. coli?

The functional interaction between thymidylate synthase (thyA) and folate metabolism in Xylella fastidiosa differs significantly from model organisms like E. coli, reflecting adaptations to its unique ecological niche:

  • Gene Organization and Regulation:

    • X. fastidiosa: thyA often exists in operons with genes specific to xylem colonization, suggesting co-regulation with pathogenicity factors

    • E. coli: thyA is typically co-regulated with other DNA synthesis genes

  • Metabolic Bypass Mechanisms:

    • X. fastidiosa: Less metabolic redundancy and fewer bypass pathways for thymidylate synthesis

    • E. coli: Contains alternative pathways (thyX in some strains) and can better tolerate thyA mutations

  • Folate Utilization Efficiency:

    • X. fastidiosa: Adapted for efficient folate recycling in folate-limited xylem environments

    • E. coli: Optimized for rapid growth in nutrient-rich environments

  • Stress Response Integration:

    • X. fastidiosa: thyA activity appears linked to stress response pathways that are activated during plant colonization

    • E. coli: thyA regulation is more tightly linked to cell cycle control

  • Dihydrofolate Reductase Interaction:

    • X. fastidiosa: May have unique interactions between thyA and folate reductase enzymes specific to plant pathogenic bacteria

    • E. coli: Well-characterized relationship between thyA and FolA (DHFR), with known alternative enzymes like FolM

These differences highlight the specialized adaptation of X. fastidiosa's thymidylate synthesis pathway to survive in the nutrient-limited xylem environment of plants. Understanding these distinctions is crucial for developing targeted approaches to disrupt X. fastidiosa metabolism without affecting beneficial microorganisms .

How can recombinant thyA be used to investigate Xylella fastidiosa virulence mechanisms?

Recombinant thyA can serve as a valuable tool for investigating X. fastidiosa virulence mechanisms through several methodological approaches:

  • Structure-Function Analysis:

    • Generate site-directed mutants targeting conserved and variable regions of thyA

    • Correlate structural changes with altered virulence in plant infection models

    • Identify regions that may interact with plant defense compounds

  • Metabolic Dependency Studies:

    • Use recombinant thyA to complement ΔthyA mutants during different stages of infection

    • Determine when and where thymidylate synthesis is most critical for pathogenesis

    • Measure changes in virulence-associated behaviors (biofilm formation, motility) when thyA function is modulated

  • Protein-Protein Interaction Network Mapping:

    • Employ recombinant thyA as bait in pull-down experiments to identify interaction partners

    • Validate interactions using techniques like bimolecular fluorescence complementation

    • Construct an interaction network connecting thyA to known virulence factors

  • Inhibitor Screening Platform:

    • Use purified recombinant thyA to screen plant-derived compounds for inhibitory activity

    • Assess whether compounds that inhibit thyA in vitro also reduce virulence in planta

    • Develop structure-activity relationships for potential anti-virulence compounds

Such approaches have revealed that disruption of metabolic pathways like those involving the PD1311 gene (which encodes a putative acyl-CoA synthetase) can significantly impair X. fastidiosa's ability to cause disease symptoms in grapevines, suggesting that metabolic enzymes like thyA may similarly play important roles in the virulence process beyond their primary metabolic functions .

What methodologies can determine if thyA expression levels correlate with symptom development in infected plants?

To determine if thyA expression levels correlate with symptom development in plants infected with Xylella fastidiosa, researchers should implement a multi-faceted methodological approach:

  • Time-course expression analysis:

    • Quantitative RT-PCR to measure thyA transcript levels at different infection stages

    • RNA-seq to capture global transcriptional changes alongside thyA expression

    • In situ hybridization to localize thyA expression within infected plant tissues

  • Reporter strain development:

    • Create X. fastidiosa strains with thyA promoter-reporter fusions (e.g., GFP, luciferase)

    • Monitor reporter expression in planta using confocal microscopy or bioluminescence imaging

    • Correlate spatial and temporal patterns of expression with symptom progression

  • Controlled expression systems:

    • Develop inducible promoter systems to modulate thyA expression levels

    • Assess the impact of varied expression on symptom development and bacterial population dynamics

    • Determine threshold expression levels required for disease progression

  • Correlation analysis:

    • Establish standardized symptom scoring systems for each host plant species

    • Measure bacterial population size, thyA expression, and symptom severity at multiple timepoints

    • Perform statistical analyses (regression, path analysis) to determine direct and indirect relationships

  • Comparative analysis across hosts:

    • Compare thyA expression patterns in resistant versus susceptible plant varieties

    • Analyze expression in different plant species with varying susceptibility to X. fastidiosa

    • Determine if host-specific factors influence thyA expression and symptom development

This comprehensive approach would help establish whether thyA expression is a driver of pathogenicity or merely a consequence of other virulence mechanisms, similar to studies that have linked metabolic genes like PD1311 to critical virulence behaviors in X. fastidiosa .

How can researchers design inhibitors targeting Xylella fastidiosa thyA without affecting host plant metabolism?

Designing inhibitors that selectively target X. fastidiosa thyA without affecting host plant metabolism requires a methodical approach leveraging structural and biochemical differences between bacterial and plant thymidylate synthases:

  • Comparative structural analysis:

    • Solve the crystal structure of recombinant X. fastidiosa thyA

    • Perform in silico structural alignments with plant thymidylate synthases

    • Identify bacterial-specific binding pockets or interaction surfaces

  • Selectivity screening cascade:

    • Develop a primary assay using purified recombinant X. fastidiosa thyA

    • Implement counter-screening against purified plant thymidylate synthases

    • Calculate selectivity indices for promising compounds

  • Structure-based design strategy:

    • Use computational docking to identify compounds that exploit bacterial-specific features

    • Focus on allosteric sites unique to bacterial enzymes rather than highly conserved active sites

    • Design compounds that interact with residues showing low conservation between kingdoms

  • Cellular validation methodology:

    • Test compounds against X. fastidiosa cultures for growth inhibition

    • Assess effects on plant cell cultures to confirm minimal host toxicity

    • Validate target engagement using thermal shift assays or activity-based protein profiling

  • In planta efficacy assessment:

    • Evaluate inhibitor efficacy in plant infection models

    • Monitor bacterial load reduction versus phytotoxicity

    • Analyze metabolomic changes in both pathogen and host to confirm selective targeting

This approach would be similar to studies that have identified metabolic vulnerabilities in X. fastidiosa, such as those associated with the PD1311 gene, which when disrupted significantly reduces bacterial survival in plant xylem while maintaining host plant viability .

What are the most common technical challenges when working with recombinant Xylella fastidiosa thyA and how can they be overcome?

Researchers working with recombinant X. fastidiosa thyA commonly encounter several technical challenges that can be addressed through specific methodological solutions:

ChallengeManifestationSolution
Protein insolubilityFormation of inclusion bodies during expressionExpress at lower temperatures (16-20°C); use solubility-enhancing fusion tags (MBP, SUMO); add chemical chaperones (arginine, trehalose) to growth media
Low expression yieldPoor protein production despite viable constructOptimize codon usage for expression host; use stronger promoters; supplement media with rare tRNAs; try different expression hosts (E. coli Rosetta strains)
Loss of enzyme activityPurified protein shows little or no catalytic functionInclude reducing agents throughout purification; add stabilizing ligands (folate analogs); optimize buffer conditions (pH 6.5-7.5, 50-150 mM NaCl)
Protein aggregation after purificationSolution turbidity or precipitation during storageAdd 5-10% glycerol to storage buffer; include mild detergents (0.01% Triton X-100); store at -80°C in small aliquots to avoid freeze-thaw cycles
Inconsistent activity assay resultsVariable measurements between replicatesStandardize substrate preparation; ensure anaerobic conditions during assays; use internal controls; prepare fresh tetrahydrofolate solutions immediately before use
Difficulty creating structure-function mutantsMutations destabilize protein structureUse guided approaches based on sequence conservation analysis; implement stability prediction algorithms before designing mutations; test multiple substitutions at each position

These technical challenges are comparable to those encountered with other metabolic enzymes from X. fastidiosa, such as the difficulties reported in expressing and characterizing the PD1311 gene product, which required careful optimization of expression conditions to maintain functional activity .

How can researchers effectively differentiate between primary metabolic effects and virulence-related impacts when studying thyA in Xylella fastidiosa?

Differentiating between primary metabolic effects and virulence-related impacts when studying thyA in X. fastidiosa requires a systematic experimental approach:

  • Conditional expression systems:

    • Develop inducible or repressible thyA constructs in X. fastidiosa

    • Titrate thyA expression to levels that maintain minimal metabolic function

    • Assess whether virulence phenotypes can be uncoupled from growth effects

  • Metabolic supplementation experiments:

    • Supplement growth media or plant systems with thymidine to bypass thyA requirement

    • Determine if supplementation restores growth but not virulence phenotypes

    • Use stable isotope-labeled thymidine to track utilization in different conditions

  • Point mutation analysis:

    • Create catalytic versus regulatory domain mutations in thyA

    • Identify mutations that affect virulence signaling without completely eliminating enzymatic function

    • Characterize these mutations biochemically and in planta

  • Temporal expression control:

    • Implement time-resolved expression systems (e.g., stage-specific promoters)

    • Express thyA only during certain infection phases

    • Determine critical windows where thyA activity influences virulence

  • Interaction partner assessment:

    • Identify proteins that interact with thyA using pull-down experiments

    • Determine if these partners are involved in virulence pathways

    • Disrupt specific interactions to assess virulence impact without affecting catalytic function

This approach is similar to studies on other X. fastidiosa metabolic genes like PD1311, where researchers differentiated between general growth effects and specific virulence impacts by analyzing multiple phenotypes including biofilm formation, cell aggregation, and plant colonization capabilities .

What specialized equipment and methodologies are required for high-throughput screening of compounds targeting Xylella fastidiosa thyA?

Establishing a high-throughput screening (HTS) platform targeting X. fastidiosa thyA requires specialized equipment and methodologies:

  • Enzyme production infrastructure:

    • Automated protein expression systems (e.g., Bioneer ExiProgen)

    • ÄKTA or similar automated chromatography systems for rapid, reproducible purification

    • Quality control instruments (dynamic light scattering, circular dichroism) to verify protein integrity

  • Assay development components:

    • UV-Vis plate readers capable of detecting absorbance changes at 340 nm for NADPH oxidation

    • Fluorescence-based alternative assays using modified substrates with higher sensitivity

    • Liquid handling robotics (e.g., Hamilton, Beckman) for precise reagent dispensing

  • Compound management systems:

    • Automated compound storage (−20°C or −80°C) with low-humidity environments

    • Acoustic dispensing technology (e.g., Echo from Labcyte) for nanoliter transfers

    • Barcode tracking systems integrated with laboratory information management software

  • Data analysis platform:

    • Automated curve fitting software for IC50 determination

    • Statistical packages for hit identification and validation

    • Cheminformatics tools for structure-activity relationship analysis

  • Secondary screening methodology:

    • Thermal shift assays (differential scanning fluorimetry) to confirm target engagement

    • Surface plasmon resonance or isothermal titration calorimetry for binding kinetics

    • X. fastidiosa growth inhibition assays in specialized media mimicking xylem conditions

  • Counter-screening capabilities:

    • Parallel assays using human and plant thymidylate synthases

    • Cytotoxicity assessment platforms for mammalian and plant cells

    • Microfluidic systems for monitoring effects on beneficial microorganisms

This infrastructure enables the screening of large compound libraries (50,000-500,000 compounds) to identify selective inhibitors of X. fastidiosa thyA that could potentially disrupt bacterial metabolism without affecting the host plant, similar to approaches that have identified compounds targeting other essential X. fastidiosa enzymes.

What novel approaches could integrate thyA research with broader systems biology studies of Xylella fastidiosa pathogenicity?

Integrating thyA research with systems biology approaches offers promising avenues for understanding X. fastidiosa pathogenicity more comprehensively:

  • Multi-omics integration platforms:

    • Combine transcriptomics, proteomics, and metabolomics data with thyA functional analysis

    • Develop computational models mapping thyA activity to broader metabolic networks

    • Implement machine learning algorithms to identify non-obvious relationships between thyA and virulence factors

  • Single-cell technologies:

    • Apply single-cell RNA-seq to X. fastidiosa populations in planta

    • Identify subpopulations with differential thyA expression during infection

    • Correlate thyA expression patterns with spatial location in xylem vessels

  • Interspecies interaction networks:

    • Study how thyA activity influences interactions with other microbiome members

    • Examine competitive or synergistic relationships mediated by thyA-dependent metabolites

    • Develop co-culture systems to model these interactions in controlled environments

  • Host-pathogen interface analysis:

    • Implement proximity labeling techniques to identify host proteins interacting with thyA-associated pathways

    • Use tissue-specific transcriptomics to correlate plant defense responses with bacterial thyA expression

    • Develop plant-bacteria co-expression networks centered on thymidine metabolism

  • In situ metabolic imaging:

    • Develop biosensors for thyA activity or its metabolic products

    • Implement these in microfluidic devices mimicking xylem vessels

    • Visualize metabolic activities during biofilm formation and host colonization

These approaches could reveal how thyA contributes to complex phenotypes like those observed in studies of other metabolic genes such as PD1311, where disruption affected multiple virulence-associated behaviors including motility, aggregation, and biofilm formation in X. fastidiosa .

How might CRISPR-Cas9 technologies advance the study of thyA function in Xylella fastidiosa?

CRISPR-Cas9 technologies offer transformative approaches for studying thyA function in X. fastidiosa:

  • Precise genome editing capabilities:

    • Generate clean thyA deletions without polar effects on neighboring genes

    • Create point mutations to distinguish catalytic from regulatory functions

    • Introduce specific thyA variants from different subspecies to study host adaptation

  • Tunable gene expression systems:

    • Implement CRISPR interference (CRISPRi) to achieve partial thyA repression

    • Develop CRISPR activation (CRISPRa) to enhance thyA expression in specific conditions

    • Create inducible systems for temporal control of thyA expression during infection

  • In situ functional genomics:

    • Perform multiplexed gene editing to study thyA interactions with other metabolic pathways

    • Create reporter fusions at the native thyA locus to monitor expression without disrupting genomic context

    • Generate conditional thyA mutants activated by specific environmental signals

  • High-throughput functional screening:

    • Deploy CRISPR libraries targeting thyA regulators to identify novel control mechanisms

    • Screen for bacterial or plant factors that influence thyA expression or function

    • Identify synthetic lethal interactions with thyA through genome-wide CRISPR screens

  • In planta editing applications:

    • Modify thyA in bacteria directly within plant hosts using delivery via bacteriophage or conjugation

    • Study the consequences of thyA modulation in the natural infection environment

    • Track evolutionary responses to thyA modification during plant colonization

These technologies could significantly accelerate understanding of how thyA contributes to X. fastidiosa survival in the xylem environment, similar to insights gained from studies of other metabolic genes like PD1311, which was shown to be essential for bacterial adaptation to plant conditions .

What are the most promising approaches for translating basic thyA research into strategies for controlling Xylella fastidiosa-related plant diseases?

Translating basic thyA research into practical control strategies for X. fastidiosa-related plant diseases requires several complementary approaches:

  • Rational inhibitor development:

    • Structure-based design of thyA inhibitors based on high-resolution crystal structures

    • Optimization for xylem mobility and stability in plant vascular systems

    • Formulation development for effective delivery through various application methods (foliar, soil drench, trunk injection)

  • Host-induced gene silencing:

    • Engineer plants to produce double-stranded RNA targeting thyA

    • Optimize dsRNA design for uptake during X. fastidiosa feeding

    • Develop transgenic resistant varieties with constitutive or inducible silencing capabilities

  • Phage therapy approaches:

    • Identify bacteriophages that specifically target X. fastidiosa

    • Engineer phages to deliver CRISPR-Cas systems targeting thyA

    • Develop phage cocktails that target multiple essential genes including thyA

  • Competitive exclusion strategies:

    • Develop non-pathogenic X. fastidiosa strains with modified thyA

    • Engineer these strains to outcompete pathogenic variants in xylem colonization

    • Optimize application timing and methods for preventative treatment

  • Diagnostic platform development:

    • Create thyA expression-based biosensors for early detection

    • Develop point-of-care nucleic acid tests targeting thyA variants

    • Implement machine learning algorithms to predict disease progression based on thyA expression patterns

These translational approaches could build on findings from studies of metabolic genes like PD1311, which demonstrated that targeting metabolic pathways can significantly reduce X. fastidiosa virulence and disease progression . Additionally, understanding the role of intersubspecific recombination in thyA evolution could inform strategies to prevent the emergence of new pathogenic variants through recombination .

What are the key considerations for designing comprehensive research programs focused on Xylella fastidiosa thyA?

A comprehensive research program focused on X. fastidiosa thyA should incorporate multiple interconnected dimensions to maximize impact and translational potential. Key considerations include:

  • Multidisciplinary team composition:

    • Structural biologists for protein characterization

    • Molecular microbiologists for genetic manipulation

    • Plant pathologists for in planta studies

    • Computational biologists for systems-level analysis

    • Chemists for inhibitor development

  • Technological infrastructure requirements:

    • Protein production and characterization facilities

    • Advanced microscopy for host-pathogen interaction visualization

    • Omics platforms for comprehensive molecular profiling

    • High-performance computing for modeling and data analysis

    • Greenhouse and field testing capabilities

  • Research question prioritization:

    • Balance basic mechanistic studies with applied translational research

    • Address both fundamental enzyme properties and their ecological relevance

    • Consider evolutionary aspects alongside immediate disease management goals

    • Integrate thyA research with broader X. fastidiosa pathogenicity mechanisms

  • Stakeholder engagement strategy:

    • Involve agricultural extension services for field testing

    • Engage regulatory agencies early for translational applications

    • Collaborate with affected industry sectors (wine, citrus, olive)

    • Develop communication channels with growers and the public

This comprehensive approach allows researchers to connect molecular mechanisms to ecosystem-level processes, similar to successful studies of other X. fastidiosa metabolic genes like PD1311, which revealed connections between basic metabolism and complex virulence behaviors .

What experimental standards should be established for reproducible research on recombinant Xylella fastidiosa thyA?

To ensure reproducibility in recombinant X. fastidiosa thyA research, the following experimental standards should be established:

  • Genetic construct documentation:

    • Complete sequence verification of expression constructs

    • Standardized nomenclature for mutations and fusion proteins

    • Public repository deposition of all constructs with detailed annotation

  • Protein production protocols:

    • Detailed expression conditions (strain, media, temperature, induction parameters)

    • Step-by-step purification protocols with buffer compositions

    • Quality control metrics (purity assessment, activity validation)

  • Activity assay standardization:

    • Reference substrate preparation methods

    • Standard assay conditions (temperature, pH, buffer composition)

    • Validated positive and negative controls

    • Statistical analysis guidelines for data interpretation

  • In planta experimental design:

    • Standardized inoculation methods and bacterial quantification protocols

    • Defined plant growth conditions and developmental stages

    • Consistent symptom scoring systems for each host plant species

    • Minimum sample sizes and statistical power calculations

  • Data reporting requirements:

    • Raw data availability in public repositories

    • Standardized data formats for enzyme kinetics

    • Complete methods documentation in publications

    • Sharing of analytical code and custom software

These standards would facilitate comparison between studies from different laboratories and ensure that findings regarding X. fastidiosa thyA are robust and reproducible, similar to the standardized approaches that have enabled comparative analyses of other X. fastidiosa virulence factors across multiple studies .

How can international collaboration enhance research efforts on thyA in different Xylella fastidiosa subspecies affecting diverse crops globally?

International collaboration can significantly enhance thyA research across X. fastidiosa subspecies through several structured approaches:

  • Global strain repository development:

    • Establish centralized collections of well-characterized isolates from different regions

    • Implement standardized typing methods focusing on thyA variants

    • Create a searchable database linking thyA sequences to host range and geographical origin

  • Coordinated research networks:

    • Form specialized working groups focusing on different aspects of thyA biology

    • Implement common experimental protocols across laboratories

    • Develop shared resources (antibodies, purified proteins, genetic constructs)

  • Integrated surveillance systems:

    • Deploy thyA-based detection methods in global monitoring programs

    • Track the emergence and spread of novel thyA variants

    • Correlate thyA sequence data with pathogenicity in different crop systems

  • Capacity building initiatives:

    • Provide training in advanced techniques for researchers in emerging affected regions

    • Develop mobile laboratory capabilities for field research in remote areas

    • Create open educational resources on thyA research methodologies

  • Regulatory harmonization:

    • Develop international standards for thyA-targeted control strategies

    • Create shared protocols for efficacy assessment of interventions

    • Establish common frameworks for field testing novel management approaches

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.